www strandls com Genetics became Genomics and Biology
www. strandls. com
“Genetics became Genomics and Biology became an Information Science” 1950 Human Genome Project Development of Sanger Sequencing Discovery of DNA structure 1960 Watson & Crick Nobel Prize in 1962 1970 1980 Frederick Sanger Nobel Prizes in 1958 & 1980 1990 2000 Bill Clinton & Francis Collins Next Gen Sequencing 2010 Lander / Broad Mapping
Next Generation Sequencing Costs
00: 02: 04 Strand Life Sciences: Genesis The first academic spin-off in India, from the Indian Institute of Science, Bangalore, in 2000 4
Research Bioinformatics Science Clinic Primary Bioinformatics Translational Bioinformatics Analysis / Interpretation Primary Bioinformatics Informatics Measurement
STRAND LIFE SCIENCES CORPORATE OVERVIEW www. strandls. com
Agenda I. Who is Strand? II. Our Capabilities III. Our Executive Team IV. Our Partners V. Our Strengths www. strandls. com
Who is Strand? Founded in 2000, headquartered in Bangalore, India with US corporate headquarters in San Francisco India’s first major academic spin-off has 230 employees; 50% computer science and 50% life science & clinical Ph. Ds Leaders in genomic research software with 2, 000 licenses worldwide and deep relationships with large corporations such as Agilent and L’Oreal Mature personalized medicine business in India www. strandls. com
Our Capabilities • • Personalized Medicine LDT Testing for Oncology & Inherited Diseases • • Strand. Omics™ A platform for variant interpretation and reporting built for interpreters by interpreters • • • Gene. Spring® Strand® NGS Gene expression analysis software covering microarray and newer NGS technologies www. strandls. com
Genomic Software We build products that are used by thousands of researchers around the world to gain insights into the Omics world: the world of genes, proteins, metabolites, epigenomes and metagenomes. These insights help us understand what roles these molecules play in health and in disease. And how these roles can be manipulated to design cures. These insights have contributed to a large body of knowledge captured in several thousand scientific publications. Capability Description Gene. Spring® Software for Gene Expression analysis offering an interactive computing environment Strand® NGS software solution for full-fledged data analysis for all major sequencing applications Strand. Omics™ A platform for variant interpretation and reporting built for interpreters by interpreters Heptox™ Unique Hepato. Toxicity Predictive Platform Currently, Strand software products are offered in the U. S. for research only www. strandls. com
Personalized Medicine We enable clinicians to derive insights from their patient's genomes. We extract this vast genomic information and distill it down to its very essence using knowledge generated from cutting-edge research. Our powerful capabilities enable clinicians to pinpoint the root cause of disease and identify the right treatment, including treatments in clinical trials. They also enable clinicians to identify patients at increased risk for many diseases including cancer, and help the clinician and patient work together to prevent disease. Capability* Description Cancer Panel Strand® Germline Test and Strand® Somatic 48 Gene Test are offered as a standard of cancer care and to support risk screening Speciality Panels Strand® Eye Genomic Test and Strand ® Cardio Genomic Test Genetic Panels & Known Mutations Strand® Rare Disease Test and Strand ® Single Mutation Confirmation Test are offered in pre-natal screening, neo-natal check-ups and single mutation confirmations *These panels are research only in the U. S. www. strandls. com
Experienced Management Team & Thought Leadership VIJAY CHANDRU, Ph. D SCOTT STORRER RAMESH HARIHARAN, Ph. D KALYANASUNDARAM 'KAS' SUBRAMANIAN, Ph. D THIRU P. REDDY Co-founder, Chairman and Chief Executive Officer President, Strand Genomics Co-founder and Chief Technology Officer Chief Scientific Officer Executive Vice President, Business Operations • MIT (Ph. D), Purdue, IISc • Technology Pioneer – • Boston University • General Electric, CIGNA, • Courant(Ph. D), Max Plank, • Johns Hopkins (Ph. D), IIT • West Virginia • Bayer, Incyte WEF • Fellow Indian Academy of Sciences & Engineering Cardinal Health, Genomind IISc , IIT –D • MIT TR 100 -B • Novartis, Entelos Talent from Premier Institutions & Universities Board of Directors VIJAY CHANDRU, Ph. D Co-founder, Chairman & CEO DAVID WETHERELL Managing Partner, Biomark Capital RAVI VENKATESAN Ex-Chairman, Microsoft India RAMESH HARIHARAN, Ph. D Co-founder and CTO DOUGLAS LIND, MD Managing Director, Biomark Capital Advisory Board CHARLES CANTOR, Ph. D ERIC EASTMAN, Ph. D CHARLES De. LISI, Ph. D KAL RAMNARAYAN, Ph. D SWAMI MANOHAR, Ph. D Co-founder D. BALA SUBRAMANIAN, Ph. D V. VINAY, Ph. D Co- founder www. strandls. com
Partners & Customers Europe China & Japan Australia North America India www. strandls. com
Strand Strengths Leaders in genomic software with 1, 400 licenses worldwide and growing rapidly 14 -year-old company, financially strong and continually investing in innovation Access to several hundred computer science, life science and clinical science Ph. Ds Unmatched capabilities in genomic software and personalized medicine www. strandls. com
Thank you
- Slides: 15